Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Showing 11 of 0 results

Early research (Phase 1)Study completedNCT03402438
What this trial is testing

Renal Impairment Study

Who this might be right for
Clinical Trial, Phase I
Bayer 36
Early research (Phase 1)Study completedNCT05032235
What this trial is testing

Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Renal Impairment
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)UnknownNCT04414852
What this trial is testing

Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function

Who this might be right for
Subjects With Impaired Renal Function and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT05865171
What this trial is testing

Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment

Who this might be right for
Renal Impairment
Vertex Pharmaceuticals Incorporated 16
Early research (Phase 1)Study completedNCT02431481
What this trial is testing

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Who this might be right for
Normal Renal FunctionImpaired Renal Function
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT01711723
What this trial is testing

Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment

Who this might be right for
Atherosclerosis
GlaxoSmithKline 16
Early research (Phase 1)WithdrawnNCT03630029
What this trial is testing

RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD

Who this might be right for
Acute Kidney Injury
Renibus Therapeutics, Inc.
Early research (Phase 1)Study completedNCT04176536
What this trial is testing

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body

Who this might be right for
HealthyChronic Kidney Disease
Boehringer Ingelheim 28
Early research (Phase 1)Study completedNCT06775834
What this trial is testing

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT03165071
What this trial is testing

Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease

Who this might be right for
Severe Renal ImpairmentHealthy Subjects
Idorsia Pharmaceuticals Ltd. 16
Early research (Phase 1)Study completedNCT02289703
What this trial is testing

A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis

Who this might be right for
End-Stage Renal Disease
Janssen Research & Development, LLC 16

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation